Researchers at the University of Cincinnati (UC) are collaborating in a study that will pinpoint and alter a specific gene in people with HIV. The hope is that process will lower the amount of HIV in the person’s body, and could possibly lead to the development of a cure for HIV.
By targeting the C-C motif chemokine receptor (CCR5) gene, Carl Fichtenbaum, MD, professor in the Division of Infectious Diseases in the Department of Internal Medicine at the UC College of Medicine, and a principal investigator on the study, and his colleagues at Case Western Reserve University (CWRU), will modify that gene creating a mutation that prohibits the entry of HIV into specific white blood cells called lymphocytes.
“On the surface of lymphocytes, which are the cells that are mainly infected by HIV, there is a receptor,” Fichtenbaum says. “Think of it like a lock to a door and HIV as a key. HIV has a little protein that juts out and that fits right into the lock of that CCR5 receptor. People who are born without that receptor cannot be infected with HIV. People who are born with only half of them seem to suffer less ill effects from HIV.”
Known as the TRAILBLAZER study, or “T-Cell Reinfusion After Interfering With Lymphocyte Binding Location of AIDS Virus Through Zinc-finger-nuclease Elimination of CCR5 Receptors” UC researchers will collaborate with CWRU in Cleveland and the University of California-San Francisco (UCSF). Most of the 30 patients in the study will be enrolled this year and next year and researchers will follow them for two years.
“The CCR5 gene is critical for sustaining HIV infection in humans,” says Fichtenbaum. “In this study, we are going to remove white blood cells from people who are infected, sort out their lymphocytes and about two-thirds of the people are going to get them modified. The CCR5 gene will be removed using zinc finger nucleases technology.”
Fichtenbaum says the zinc finger nucleases technology is a virus developed by scientists that is called a vector. That vector is inserted into a nuclease, which is an enzyme that cuts like scissors.
“You put a little homing device on that vector and instruct it to cut out the CCR5 gene,” Fichtenbaum says. “That homing device snips on either side of the gene and creates a hole that is then repaired by a technology called end-joining, where the two ends are joined back together using a different enzyme. It’s a normal, natural DNA-repair enzyme that happens all the time in our body.”